Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Infections 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 COVID-19 1 Breast Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Adenocarcinoma Of Esophagus 1

Interventions

Etoposide 79 Carboplatin 67 Cisplatin 58 durvalumab 29 Irinotecan 29 Radiotherapy 27 atezolizumab 23 Topotecan 21 anlotinib 19 Nivolumab 15 Drug Therapy 15 Radiosurgery 14 Gemcitabine 13 apatinib 12 Paclitaxel 12 toripalimab 10 Platinum 10 Docetaxel 10 tislelizumab 9 Temozolomide 9 PM 01183 8 pembrolizumab 7 olaparib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Bevacizumab 7 Albumin-Bound Paclitaxel 7 irinotecan sucrosofate 6 Counseling 6 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × monalizumab × Clear all

NCT05903092 2026-04-29

MOZART

Hoosier Cancer Research Network

Phase 2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡